Summary:
- Researchers at the University of Texas MD Anderson Cancer Center have identified a new biomarker, called PHLPP1, that can predict the aggressiveness of certain types of cancer.
- The study found that lower levels of PHLPP1 are associated with more aggressive and invasive forms of cancer, including breast, lung, and prostate cancer.
- This discovery could lead to the development of new diagnostic tools and personalized treatment strategies for patients with these types of cancer, as the PHLPP1 biomarker could help identify those at higher risk of developing more aggressive disease.